Concepedia

Katriina Peltola

KP

34

Publications

5.4K

Citations

23

H-Index

2003

Active since

Affiliations

Helsinki University Hospital(Current)

University of Helsinki

Institut Gustave Roussy

Dana-Farber Cancer Institute

Memorial Sloan Kettering Cancer Center

Katriina Peltola is an author at Helsinki University Hospital specializing in medicine, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2003–2024

34

Publications

34

Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma

Toni K. Choueiri, Bernard Escudier, Thomas Powles et al. · New England Journal of Medicine · 2015 · 1.2K citations · Full text

Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial

Toni K. Choueiri, Bernard Escudier, Thomas Powles et al. · The Lancet Oncology · 2016 · 927 citations · Full text

, , +8

CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer

Yelena Y. Janjigian, Johanna C. Bendell, Emiliano Calvo et al. · Journal of Clinical Oncology · 2018 · 613 citations · Full text

Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long‐term follow‐up of the randomized, open‐label, phase 3 CheckMate 025 trial

Robert J. Motzer, Bernard Escudier, Saby George et al. · Cancer · 2020 · 327 citations · Full text

Pim‐1 kinase promotes inactivation of the pro‐apoptotic Bad protein by phosphorylating it on the Ser<sup>112</sup> gatekeeper site

Teija L. T. Aho, Jouko Sandholm, Katriina Peltola et al. · FEBS Letters · 2004 · 314 citations

, , +16

Rows per page

1–5 of 34